Found 13 matching trials
Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy PHASE4 The purpose of this study is to evaluate the impact of a physician directed...
Show More Location
California Liver Institute
Learn More & Join Trial
An Observational Study Examining the Use of Triple Combination Therapy With Boceprevir, Peginterferon Alfa-2a and Ribavirin in the Re-Treatment of Chronic Hepatitis C Patients N/A This prospective, national, multicenter, non-interventional study examined ...
Show More Location
Multiple Locations
Learn More & Join Trial
HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin PHASE3 The primary objective of this study is to evaluate the safety and efficacy ...
Show More Location
Hospital Clinic i Provincial de Barcelona
Learn More & Join Trial
Safety and Efficacy of Boceprevir/Peginterferon Alfa-2a/Ribavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus (HCV) Genotype 1 Participants (P07755) PHASE3 The primary purpose of this study is to compare the efficacy of two bocepre...
Show More Location
Multiple Locations
Learn More & Join Trial
Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1 PHASE3 This study will assess the safety and efficacy of alisporivir (ALV) and boc...
Show More Location
Novartis Investigational Site
Learn More & Join Trial
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir NA 1. The primary objective is to study the comparative effectiveness and tole...
Show More Location
Louis Stokes Cleveland VA medical center
Learn More & Join Trial
Impact of Antiviral Therapy on Gastroesophageal Varices. N/A Hepatitis C virus (HCV) chronic infection affects 200 million people worldw...
Show More Location
Multiple Locations
Learn More & Join Trial
An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C N/A This prospective, multicenter, observational cohort study will evaluate the...
Show More Location
Multiple Locations
Learn More & Join Trial
A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C PHASE4 This open-label, multicenter, treatment response guided study will evaluate...
Show More Location
Multiple Locations
Learn More & Join Trial
Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C PHASE4 Response-guided triple-therapy with boceprevir (BOC) in combination with pe...
Show More Location
Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna
Learn More & Join Trial